Hypo- and hyper alphalipoproteinemia and genetic abnormalities in reverse cholesterol transport system

A. Matsuyama, S. Yamashita

Research output: Contribution to journalReview article

Abstract

The risk of atherosclerosis has been known to be inversely correlated with the plasma concentration of high-density lipoprotein (HDL)-cholesterol, and we now know HDL plays a protective role against atherosclerosis. The most important mechanism, by which HDL could exert their anti-atherogenic role, is certainly the removal of excess cholesterol from peripheral cells and its transport to the liver, a process commonly called "reverse cholesterol transport system". In this system, many proteins are involved, i.e., ABC1, LCAT, CETP, HTGL and SR-BI. Abnormalities of these proteins reduce the efficacy of the system, and cause abnormalities of HDL and atherosclerosis. In this paper, we review the recent findings on the molecular mechanism of reverse cholesterol transport system, and then discuss hypo- and hyperalphalipoproteinemia, which are caused by genetic abnormalities of the key players.

Original languageEnglish
Pages (from-to)2729-2734
Number of pages6
JournalNippon rinsho. Japanese journal of clinical medicine
Volume57
Issue number12
Publication statusPublished - 12-1999
Externally publishedYes

All Science Journal Classification (ASJC) codes

  • Medicine(all)

Fingerprint Dive into the research topics of 'Hypo- and hyper alphalipoproteinemia and genetic abnormalities in reverse cholesterol transport system'. Together they form a unique fingerprint.

  • Cite this